Molecular identification, characterization, and antagonistic activity profiling of Bacillus cereus LOCK 1002 along with the in-silico analysis of its presumptive bacteriocins

Objectives: This research aimed to isolate, identify, and characterize a new strain of Bacillus cereus through different molecular biology approaches so that it could be further studied for therapeutic purposes against selective enteric pathogens. Materials and Methods: Pure isolates of B. cereus were prepared from buffalo yogurt samples in REMBA medium. Initially, the morphological, physiological, and biochemical properties were studied accordingly. Following the tests, the molecular identification for the strain identification was conducted through plasmid DNA extraction, PCR, agarose gel electrophoresis, and 16S rRNA sequencing up to 1.37 kb. Afterward, the antibiotic sensitivity [Epsilometer test (E-Test)] and antifungal activity were tested considering different concentrations. Being classified from the aforementioned tests, a comprehensive antimicrobial activity test was conducted using the cell-free-supernatant (CFS) of the test strain against selective enteric pathogens in humans in vitro. Besides, the different clusters of genes were identified and characterized for understanding the presumptive bacteriocins present in the CFS of the strain in silico, where molecular string properties were calculated. Finally, the evolutionary relationship among diversified bacteriocins synthesized by different Bacillus strains was studied to predict the CFS-containing bacteriocins of the new strain. Results: Purified isolates of B. cereus were Gram-positive rods and showed significant tolerance (p < 0.0001) to different concentrations of pH, phenol, bile salt, and NaCl. 16S rRNA revealed the strain as LOCK 1002, which was strongly sensitive to all the antibiotics used and resistant to selective antifungal agents. The CFS of B. cereus LOCK 1002 was found to be a very promising antagonist to all the enteric pathogens used in the culture condition. Two gene clusters were predicted to be interconnected and responsible for different presumptive bacteriocins. Conclusion: The newly identified LOCK 1002 can be a very potent strain of B. cereus in use as an antimicrobial agent for having different bacteriocin coding gene clusters.


Introduction
Bacillus cereus is a spore-forming, gram-positive bacteria capable of infecting multiple hosts and being ubiquitous [1]. Bacillus cereus was found to have a remarkable tolerance to heavy metals, bile salts, and pH up to 8 [2]. It typically has a high occurrence in dairy products and is well known for the spoilage of pasteurized milk, leading to foodborne illness [3]. As concerning as it is, multiple foodborne diseases and typically severe clinical conditions have been affiliated with B. cereus as a causative agent [4]. Especially prominent in foodborne illness, two distinct infectious characteristics (emetic or diarrheal syndrome) are linked with the release of particular potent peptide toxins and proteinaceous enterotoxins [5]. It may seem as though B. cereus is renowned for its potential as an enteropathogenic agent [6]. However, concurrent studies have elucidated that evolving strains of B. cereus, with the help of differing expansion and interchange of genetic material in the specific Bacillus gene, result in the formation of newly emerged anthrax-like clinical manifestations in mammals, especially in humans [5]. As prevalent as gastrointestinal infections can be, clinical studies demonstrated that B. cereus induces bloodstream infections, with patients exhibiting nosocomial infections [6]. Besides local and systemic infections, B. cereus in an immunocompromised individual generates multi-characteristic clinical conditions such as endophthalmitis, endocarditis, meningitis, septicemia, and encephalitis, leading to 10% of patient deaths [7]. Surprisingly, due to their ability to withstand the surrounding environmental stresses of high temperature, acidic-gastric environment, and moisture, several Bacillus species are now being utilized as probiotics. Some commercially applied Bacillus species are used industrially: B. cereus, B. subtilis, B. clausii, B. coagulans, B. polyfermenticus, B. licheniformis, and B. pumilus. Several Bacillus species show significant antimicrobial, antioxidant, anticancer, and vitamin-producing characteristics when supplemented [8]. Compared to the B. clausii and B. subtilis, selective B. cereus strains can survive longer by attaching their hydrophobic spores to the epithelial cells, which shows prominent therapeutic attributes against gut pathogenic inhabitants including-Salmonella, H. pylori, and E. coli [9]. Potential therapeutics that include prevalence analysis, virulence genes, antimicrobial susceptibility tests, and gene cluster analysis for bacteriocins are being tested to combat the rampant emergence of B. cereus infections [10]. An ever-increasing antibiotic resistance, shaped most evidently by environmental factors, is currently being assessed with the utmost strategies [11].
Bacteria are incubated in Lysogeny broth at 37°C (24 h), and 10-min centrifugation (3,000 rpm) is carried out to detach cell-free-supernatant (CFS) from cell debris. In order to get a substantially CFS, this process is performed twice [12]. According to a recent study, the CFS from Lactobacillus plantarum NIBR97, which contains nevel bacteriocins, may potentially serve as a natural disinfectant substitute for chemical ones [13]. Another study tested the potential of the CFS extracted from liquid cultures of particular local lactic acid bacteria (LAB) and yeast isolates [14]. Recent studies revealed that microorganisms like Salmonella spp., L. monocytogenes, and S. aureus can be inhibited by CFS in vitro in both the co-culture and delayed culture methods [14]. CFS from the LAB isolates is reported as a strong inhibitor of enteric pathogens when co-cultured. The inhibitory activity of CFS depends primarily on the existence of active substances secreted into the supernatant. Active microbial metabolites, including bacteriocins, which are generated and secreted by bacteria into the growth medium, can inhibit Gram-positive and Gramnegative pathogens [14]. Bacteriocins are ribosomally manufactured, post-translationally modified molecules that do not affect the producer strain but can kill closely related bacteria [15]. The effectiveness of the CFS mainly depends on the source strains, toxicity level, and proteinaceous profiles [16]. The cationic bacteriocin exploits the anionic microbial cell wall by forming ion-selective pores; thus, the permeability increases and the microbes fail to survive [17]. A recent study identified 16S rRNA from numerous B. cereus strains during their gene sequencing. Their bacteriocinogenic production activity was shown in culture conditions against four different microbes, including S. aureus, E. coli, B. cereus, and Salmonella spp. [18]. A few bacteriocins have been approved for preclinical applications, such as mutacin 1,140, microbisporicin, and duramycin; due to their significant activities against Clostridium difficile infection, multiresistant pathogens, and cystic fibrosis, respectively [19]. Hence, pursuing novel and promising bacteriocins for clinical and therapeutic applications has become a significant demand in the future.
Considering the aforementioned information, this current research aimed to isolate a new B. cereus strain through 16S rRNA analysis, following which morphological, to be interconnected and responsible for different presumptive bacteriocins. Conclusion: The newly identified LOCK 1002 can be a very potent strain of B. cereus in use as an antimicrobial agent for having different bacteriocin coding gene clusters.
physiological, and biochemical characterizations were conducted. Afterward, the antibiotic and antifungal sensitivity were tested before subjecting the test strain to its antimicrobial profiling in response to selective enteric pathogens. Finally, systems biology-based predictions of the presumptive bacteriocins and the genes responsible for those antimicrobial protein (AMPs) networks were studied.

Isolation of B. cereus
In this study, a total of 43 milk samples were collected from buffalo yogurt and inoculated on polymyxin pyruvate eggyolk mannitol-bromothymol blue agar (PEMBA) medium, which is selective for growing B. cereus [2,18]. After successive subcultures, pure isolates were stored at −20°C with 50% PBS-glycerol [20].

Morpho-physiological and biochemical characterization
The isolated B. cereus was characterized morphologically by its colony size, shape, and Gram staining, and physiologically by analyzing its growth at high pH, phenol, bile salts, and NaCl [18]. Besides, the biochemical characterization was conducted by catalase, coagulase, Voges-Proskauer, indole, urease, nitrate reductase, β-Galactosidase, and H 2 S production tests [21].

Molecular analysis of the B. cereus strain
The strain was identified by sequencing the 16S rRNA gene. The ribosomal RNA was extracted and amplified using the Veriti ® 99 well Thermal Cycler PCR system (Model No. 9902) with the "Universal 16S rRNA Specific Primer" [18]. Following the observation of the desired PCR amplicon, it was purified enzymatically for subjecting to the "Sanger sequencing." The bi-directional sequencing was conducted by using the BDT v3.1 Cycle Sequencing Kit on the ABI 3,730xl Genetic Analyzer, where 8F and 1,401R primers were used [2,18]. Afterward, the consensus sequence was uploaded in NCBI's FASTA format through Gene Bank, and an accession number for the targeted strain was received. Finally, the phylogenetic tree was constructed to determine the evolutionary relationship of the strain of B. cereus. The qualitative relationship study was conducted by MEGAX [22], whereas the quantitative relationship measurement was determined using Phylogeny.fr [23].

Antibiotic and antimycotic sensitivity profiling
The antibiotic sensitivity test of the identified B. cereus strain was carried out by epsilometer, where the MIC 50 and MIC 90 were tested, considering distinguishable minimum inhibitory concentrations (MIC) (μg/ml) of different antibiotics [24]. On the other hand, selective antifungal agents were used in different concentrations as the antimycotic agents, namely, viodine (%, v/v), polydine (%, w/v), nystatin (%, v/v), and fluconazole (%, w/v) [25] to assess the sensitivity of the B. cereus strain.

Antimicrobial activity profiling of the B. cereus strain
Firstly, the CFS of the overnight pure culture broth was collected through centrifugation at 15,000 rpm (22,388 g) using a refrigerated centrifuge machine (NEUATION; Model No. UC02R) for ensuring maximum output [26]. The pure supernatant was placed into a nutrient agar medium to have a stick-plate co-culture with two different enteric pathogens in each petri dish at a time [27]. In that case, the CFS was kept in the middle portion, while the two enteric pathogens were seeded at the two opposite ends of the Petri plate. Every 24 h for 3 days, the pathogenic proliferation patterns near the CFS margins were measured (mm) [18].

In silico analysis of the presumptive bacteriocins of the B. cereus CFS
Several bacteriocins are biosynthesized naturally by B. cereus depending on their culture condition and metabolic features. In this study, several B. cereus-producing bacteriocins have been obtained from the STRING database of protein networking. Using Cytoscape 3.8.2 (https://cytoscape.org/), the bacteriocin network's nodes and edges were detected and characterized [28], which is operated via the Java Runtime Environment. Besides, the genes that code for those bacteriocins in B. cereus strains have been identified and characterized using the BACTIBASE [29] and GeneMANIA databases [30]. Finally, the bacteriocin genes of B. cereus strains were analyzed based on their nodes of string formation, regions on the chromosome; gene-fusion (GF); phylogenetic co-occurrence (PO), coexpression (CO), homology (H), experimentally defined interactions (EI); database annotation (DA), automated text mining (AT), and the total scores. The clustering of the interactive bacteriocin nodes of B. cereus was constructed with the tools Morpheus [31] and Heatmapper [32]. A complete linkage clustering of proteins with the Euclidean distance measurement method was used to assess the B. cereus bacteriocins. The interaction source of the bacteriocin nodes of B. cereus strains was identified using Cytoscape 3.8.2 [29]. Phylogenetic analysis of several B. cereus bacteriocin genes were accomplished to determine their quantitative divergence from each other via Phylogeny.fr [23] and Clustal Omega [33]. The protein clustering was conducted following the parameters: nodes of string formation; neighborhood on the chromosome; GF; PO; H; CO; EI; DA; AT; and the combined scores (CO) [32].

Morpho-physiological and biochemical characterization
In this study, 11 B. cereus isolates were purified, and the isolates exhibited medium-sized (5-7 mm) whitish colonies on PEMBA, and in Gram stain, the cells were found Gram-positive rods. The isolates were tolerant to a broad range of pH (5.0-9.0), phenol (0.3%), bile (0.3%), and NaCl (3%). The presumptive isolates in the biochemical analysis revealed positive reactions for catalase, coagulase, nitrate reductase, and Voges-Proskauer tests, but variable (+/−) results for the urease test. Table 1 shows that it was negative for galactosidase, H 2 S production, and indole reaction tests.

Molecular identification for strain selection
In PCR amplification of the 16S rRNA gene, a 1,379-bp amplicon of B. cereus was found compared to a 2-kb ladder (Fig. 1A). Following PCR purification and Sanger sequencing of the 16S rRNA gene, a consensus sequence was retrieved and uploaded into NCBI through Gene Bank, which confirmed that the strain was LOCK 1002 (accession number MH595555.1).
The phylogenetic tree encompasses a total of fifteen distinct bacterial strains of B. cereus LOCK 1002 (Fig. 1B). The target strains' higher levels of resemblance to the reference strains discovered in the GenBank allowed for the completion of their identification.    Fig. 1B and C).

Antibiotic and antimycotic sensitivity test
Quantitative assessment of the antibiotic susceptibility using the E-test showed significant susceptibility profiles of B. cereus LOCK 1002 in terms of the MIC 50 and MIC 90 values (Table 2). Considering the concentration and inhibition patterns, erythromycin was found to be the best-performing drug, with the lowest MIC 50 and MIC 90 scores of 0.091 and 1.81, respectively. In addition to erythromycin, gentamicin, amphotericin B, and tetracycline were included. In contrast, streptomycin was the least effective drug since it had the highest MIC 50 (35.5 µg/ml) and MIC 90 (54 µg/ml) values (Table 2). Similarly, increased antifungal sensitivity of B. cereus LOCK 1002 was observed with the increased concentration of viodine and polydine ( Fig. 2A). Surprisingly, this strain was found strongly resistant to Nystatin and, partially resistant to Fluconazole, producing no zone of inhibition at five different concentrations (Fig. 2B), which is alarming.

Antimicrobial activity test
The CFS of B. cereus LOCK 1002 showed maximum efficacy against E. coli with an inhibitory zone of 8 mm (Fig. 3A), whereas minimum inhibition efficiency (2 mm) was observed against S. aureus (Fig. 3C). The test strain's CFS conferred significant antagonistic effects against S. paratyphi, S. typhi, P. aeruginosa, B. megaterium, V. cholerae, and Micrococcus (Fig. 3A-D). The    quantitative measurement of their zones of inhibition (ZI) is also described ( Table 3).

Predicting the genetic interactions behind the clustering of functional bacteriocins to each other in B. cereus
In the string networking of the genes of B. cereus strains obtained from the STRING database (https://string-db. org/) and Cytoscape 3.8.2 (https://cytoscape.org/) [31], a diversified group of genes is involved in the control of biosynthesizing different AMPs (Fig. 4) . 4). More interestingly, DJ87_3435, DJ87_3436, and DJ87_3437 possess strong co-expression profiles and act as interaction sources with each other (Fig. 4) during protein synthesis. The functional bacteriocin-coding genes were connected with some other gene clusters whose function is still undefined, such as sucB, bfmBAB, pdhB, sucC, and DJ87-3438 ( Fig. 4. Among all the genes, DJ87_3435 was the strongest source-signaling gene in the protein clustering of B. cereus (Fig. 4), where three more uncharacterized proteins were observed (*, ***, ##) forming significant clusters with a radical SAM protein (**). In contrast, the cyclodehydratase domain (###) and SagB-type dehydrogenase domain protein (β*) are strongly interconnected to each other but distantly related to the other protein clusters (Fig. 4). These findings indicate that many unknown bacteriocins of B. cereus, including the LOCK 1002 strain, have yet to be profiled.

Evolutionary relationship of the established B. cereus toxins with the other peptides
It has been observed that the most common bacteriocin of Bacillus strains "cerein 7" possesses a phenomenal relationship considering its genetic makeup with some other Bacillus bacteriocins (Fig. 6); among which α/β hydrolase; cytotoxin K; hemolysin; oxidoreductase; tyrosine-type integrase; and NADH-quinone-oxidoreductase-C are evolutionary connected (Fig. 6A). In contrast, NHE-A, NHE-H, and response-regulator-transcription factor proteins are distantly related to the cerein 7 bacteriocins of B. cereus (Fig. 6B).

Discussion
Bacteriocins are a group of ribosomally synthesized proteins of different distinguishable microorganisms that have manifested significant antimicrobial activities against selective enteric pathogens [45]. More interestingly, many of these bacteriocin-producing microbes are considered foodborne pathogens, especially the strains of B. cereus [46]. In recent times, many of these pathogenic microbes have been considered clinically significant due to their therapeutic-potential peptides, which can be substituted for conventional antibiotics for clinical resistance-free applications [47]. Considering, the AMPs from different strains of Bacillus sp. are used as potential next-generation antibiotics substitutes as revealed in different recent research programs [48], where many of them show very functional properties even under stressful circumstances such as rude temperatures, the existence of chemical substances and pH [49]. Considering the aforementioned information, this study aimed to deal with the novel bacteriocin-producing B. cereus, isolated from buffalo milk through comprehensive subcultures and characterization.

Morphological & physiological observation
In the present research, morphological observations based on gram staining indicated that LOCK 1002 isolates are Gram-positive, rod-shaped bacteria that form a medium-sized, milky white colony. The isolate LOCK 1002 is motile, catalase, coagulase, and nitrates reductase positive; while showing negative reactions to H 2 S production, indole test, and β-galactosidase enzyme. The LOCK 1002 can survive a broad range of pH, Bile, Phenol, and NaCl that interpret a good tolerance level (Table 1). Similar findings were observed regarding the morphological, physiological, and biochemical features [50].

Molecular characterization of B. cereus LOCK 1002
In a phylogenetic analysis of the B. cereus LOCK 1002 16S rRNA gene compared with a total of 15 distinct bacterial strains, there was an enhanced degree of similarity between the target strains and the reference strains in the Gene Bank.  (Fig. 1B).

Antibiotic and antimycotic susceptibility of B. cereus LOCK 1002
Determining antibiotic sensitivity is necessary to formulate an empirical treatment profile and effective dosage of antibiotics against a targeted organism [51]. The E-test, a novel approach developed in the late 1980s, is preferred over other conventional antibiotic sensitivity tests for its rapidity, reliability, simplicity, and versatility in its application to microorganisms and drugs. Moreover, the interpretation is simpler due to the MIC results being quantifiable [18]. Additionally, the E-test system has shown flexibility by permitting some adjustment in inoculum size, incubation temperature, and time of reading while significantly conserving the results for the isolates being tested. In this investigation, the antibiotic susceptibility of a novel B. cereus strain, B. cereus LOCK 1002, was evaluated (Table 2), which produced results consistent with other established research [2,18]. Among the nine antibiotics used, erythromycin displayed the highest order of inhibition and inferred the greatest susceptibility of the organism. Tetracycline, gentamicin, and amphotericin B induce susceptibility against B. cereus LOCK 1002, albeit to a lesser degree than erythromycin, and are still considered to be in our pipeline of effective drugs. Our study displayed that the LOCK 1002 strain is resistant to streptomycin compared to the other antibiotics. This is in line with a lot of studies done in the past on the occurrence of resistance genes in Bacillus spp. [52]. Moreover, this study's results directly reflect the response of Bacillus spp. to various antibiotics, which is similar to the results of other studies [53].
Contemporary research has also shown the antimycotic activity of Bacillus spp., concurrent with our research [54]. Our results revealed the existence of in vitro antimycotic sensitivity of B. cereus to antimycotic agents like polydine and viodine (Povidone-iodine), which is globally renowned for infectious disease management [55]. Even though Nystatin and Fluconazole are well-known anti-fungal agents, they were surprisingly unsuccessful in producing a zone of inhibition for our strain, even at high concentrations. When antifungal medications are administered incorrectly, such as when dosages are too low or treatment sessions are too short, resistance can emerge [56,57]. On the contrary, in the presence of polydine and viodine, ZI were observed in a dose-dependent manner at different concentrations Comparative analysis between polydine and viodine showed a substantial antimycotic action of polydine with an increasing concentration in vitro (Fig. 2).

Antimicrobial activity of the CFS of B. cereus LOCK 1002
In this current research, the presence of some presumptive bacteriocins [58] was predicted in the CFS of B. cereus LOCK1002 based on their antimicrobial activity profiles against selective enteric pathogens [59], similar to the way probiotic microorganisms are used [60]. From peer-reviewed studies, it is deduced that several B. cereus strains produced novel bacteriocins, such as Cerein 7A and 8A, which exhibited antibacterial and antifungal effects against pathogenic microorganisms [61]. In this research, the CFS containing the antimicrobial peptides was found to be a very effective antagonist for E. coli, S. aureus, S. paratyphi, S. typhi, P. aeruginosa, B. megaterium, V. cholerae, and Micrococcus in the stick plate co-culture method (Fig.  3). The bacteriocins manufactured by B. cereus exhibit a wide spectrum of antagonistic action over Gram-positive and Gram-negative infections [62]. Following this study, antagonistic effects through the production of inhibitory zones were found against common enteric pathogens, some of which are multidrug-resistant and vancomycin-resistant. These inhibitory effects of CFS mention the existence of some presumptive bacteriocins of B. cereus, LOCK 1002 (Table 3). The significance of B. cereus has been increasing rapidly in research since the first outbreak of the COVID-19 pandemic because much-established literature strongly suggests that Bacillus bacteriocins can play significant roles in immunizing virus-infected individuals especially HSV, and SARS-CoV-2 [63]. Besides, it was also reported that functional AMPs can simulate the secondary immune response via successive opsonization mechanisms in the human body [64].

In silico prediction of the presumptive bacteriocins present in the CFS of B. cereus LOCK 1002
The in silico study was conducted depending on the bacteriocins synthesized from the strains of B. cereus after a comprehensive literature review and database mining. According to the STRING dataset library (https://string-db. org/) of protein networking, a group of nine genes was found to be involved in biosynthesizing diversified bacteriocins (Fig. 4). The genes acting as the interaction source of the string networks are DJ87_3435, DJ87_3436, and DJ87_3437. However, DJ87_3435 mainly encodes an undifferentiated bacteriocin (Fig. 4). Among the bacteriocin genes, three uncharacterized peptides are encoded by the genes identified as DF87_1184 (*), DJ87_2735 (***), and DJ87_3435 (##) in Figure 4. The genes for radical SAM protein (**); cyclodehydratase domain (###); and SagB-type dehydrogenase domain protein (β*) of B. cereus are significantly regulated by each other (Fig. 5). In this research, two different gene clusters are observed. According to the "kmeans clustering," DJ87_238 and DJ87_894 genes form cluster 1, while DJ87_1184, DJ87_3435, DJ87_3436, DJ87_3437, DJ87_3438, and sucB genes are involved in cluster 2 [32]. During the protein clustering process of B. cereus, the uncharacterized proteins (*, ***, ##) established vigorous clusters with a radical SAM protein (**); while the cyclodehydratase domain (###) strongly interacts with the SagB-type dehydrogenase domain protein (β*). Surprisingly, the proteins encoded by the DJ87_3436 and DJ873437 genes are comparatively distant-related to the rest of the bacteriocins (Fig. 5).

Phylogenetic clustering of B. cereus bacteriocins
According to the BACTIBASE, B. cereus strains produce a few selective bacteriocins and antimicrobial peptides [29], among which "cerein 7" is the most importantly certified one for use for therapeutic purposes and new drug formulation [64]. In this study, it is phenomenal that cerein 7 possesses a broad spectrum of evolutionary relationships with the other bacteriocins synthesized from the B. cereus strains (Fig. 5A). It has been observed that cerein 7B has strong evolutionary footprints with the α/β hydrolase; cytotoxin K; hemolysin; oxidoreductase; tyrosine-type integrase; and NADH-quinone-oxidoreductase-C proteins of other Bacillus spp. (Fig. 5B). Unlike these proteins, cerein 7 is also connected in evolutionary footprints with some other antimicrobial peptides, which include NHE-A, NHE-H, and response-regulator-transcription factor proteins (Fig. 5B). Along with B. cereus, all of these bacteriocins from different Bacillus strains can be highly important in promoting immunological feedback against pathogenic diseases [65]. Antimicrobial peptides are reported to have significant effects in suppressing microbial infections and the ROS-mediated metabolism of cancer stem cells [66], where they may be synthesized as novel AMPs for experimental applications [67,68].

Conclusion
In this research, B. cereus LOCK 1002 was isolated from yogurt samples, identified using 16S rRNA sequencing, and characterized physicochemically and biochemically in a fully controlled aseptic environment. The antimicrobial properties of the CFS of the newly identified LOCK 1002 strain against selective enteric pathogens were conducted following its consecutive antibiotic and antifungal sensitivity tests. The results showed that the LOCK 1002 strain is very susceptible to the antibiotics used. It was found to be resistant to the antifungal agents, Nystatin and Fluconazole. The antimicrobial activity of LOCK 1002 resulted in a very significant increase, making it a strong opportunistic antimicrobial candidate among all the Bacillus members. Finally, the in silico prediction and characterization of the gene clusters responsible for the antimicrobial activities were done considering their gene string network stability, interaction sources, CO, H, GF, DA, combined scores, and neighbor-joining profiles. A total of nine gene clusters were found to be associated with the synthesis of bacteriocins, and the chances of having cerein 7B in the CFS of LOCK 1002 were similar to the others, which could lead to exploring its clinical implication and establishing it as a therapeutic candidate in the coming days. Besides, it has been strongly predicted that there would be some undefined proteins clustering with the other functional bacteriocins of B. cereus.